SummerHaven Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

SummerHaven Investment Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$824K	Hold	22,756	–	–	0.44%	119
2026 Q1	$753K	Sell	22,756 -2,992	-12%	-$127K	0.46%	109
2025 Q4	$1.19M	Hold	25,748	–	–	0.68%	18
2025 Q3	$901K	Buy	25,748 +880	+4%	+$30.6K	0.52%	71
2025 Q2	$735K	Buy	24,868 +514	+2%	+$14.7K	0.48%	106
2025 Q1	$727K	Buy	24,354 +448	+2%	+$13.7K	0.51%	95
2024 Q4	$685K	Hold	23,906	–	–	0.42%	140
2024 Q3	$924K	Sell	23,906 -10,867	-31%	-$388K	0.56%	43
2024 Q2	$1.12M	Buy	34,773 +452	+1%	+$15.7K	0.74%	28
2024 Q1	$1.33M	Buy	34,321 +287	+0.8%	+$10K	0.83%	6
2023 Q4	$1.05M	Buy	34,034 +368	+1%	+$9.22K	0.67%	21
2023 Q3	$752K	Buy	+33,666	New	+$768K	0.55%	53
2022 Q3	–	Sell	-37,193	Closed	-$659K	–	212
2022 Q2	$659K	Hold	37,193	–	–	0.44%	123
2022 Q1	$757K	Buy	37,193 +1,699	+5%	+$32.1K	0.43%	138
2021 Q4	$663K	Hold	35,494	–	–	0.36%	178
2021 Q3	$701K	Buy	+35,494	New	+$768K	0.41%	184

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

SummerHaven Investment Management's COLL Position: Q2 2026 in Review

SummerHaven Investment Management held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 22,756 shares worth $824K. The position accounts for 0.44% of the portfolio, ranked #119.

SummerHaven Investment Management first reported a position in COLL in Q3 2021 and has held it in 16 quarters since. The position peaked at $1.33M in Q1 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

SummerHaven Investment Management held 22,756 shares of Collegium Pharmaceutical worth $824K as of Q2 2026.
SummerHaven Investment Management left its Collegium Pharmaceutical share count unchanged in Q2 2026.
Collegium Pharmaceutical made up 0.44% of SummerHaven Investment Management's portfolio in Q2 2026, its #119 holding.
SummerHaven Investment Management first reported a position in Collegium Pharmaceutical in Q3 2021 and has held it in 16 quarters since.
SummerHaven Investment Management's Collegium Pharmaceutical position peaked at $1.33M in Q1 2024.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on SummerHaven Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.